IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Mylan to Buy Remainder of Matrix for $133 Million

9:57 AM MDT | April 3, 2009 | Deepti Ramesh

Mylan (Canonsburg, PA) says it will purchase the stake in Matrix Laboratories (Secunderabad, India) that it does not already own from minority shareholders for about $133 million. Matrix, an active pharmaceutical ingredients and finished dosage forms supplier, will also be delisted from the Indian stock exchanges, Mylan says. The move “will provide Mylan with an opportunity for enhanced flexibility and efficiencies in managing our global technical and commercial operations platform,” says Robert J. Coury, vice chairman and CEO of...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa